Dentium CO., LTD (KRX:145720)
63,000
-1,200 (-1.87%)
At close: Jun 27, 2025, 3:30 PM KST
Dentium CO., LTD Revenue
Dentium CO., LTD had revenue of 76.83B KRW in the quarter ending March 31, 2025, a decrease of -7.13%. This brings the company's revenue in the last twelve months to 401.91B, down -1.28% year-over-year. In the year 2024, Dentium CO., LTD had annual revenue of 407.81B with 3.72% growth.
Revenue (ttm)
401.91B
Revenue Growth
-1.28%
P/S Ratio
1.35
Revenue / Employee
502.39M
Employees
800
Market Cap
543.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 407.81B | 14.62B | 3.72% |
Dec 31, 2023 | 393.19B | 37.32B | 10.49% |
Dec 31, 2022 | 355.87B | 64.34B | 22.07% |
Dec 31, 2021 | 291.53B | 61.78B | 26.89% |
Dec 31, 2020 | 229.75B | -22.84B | -9.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |